SlideShare ist ein Scribd-Unternehmen logo
1 von 18
Downloaden Sie, um offline zu lesen
GOVERNMENT AURVEDIC COLLEGE AND
HOSPITAL, PATIALA.
SESSION 2018-19
DEPARTMENT OF PEDIATRICS
COMPILTION ON: INFECTIOUS DISEASES (MEASLES,
MUMPS AND RUBELLA)
B.A.M.S.3RD
YEAR
SUBMITTED TO : SUBMITTED BY:
DR. K.K.CHOPRA MANDEEP KAUR
DR.SHALINI B.A.M.S.3RD
YEAR
DR.ASHWANI RANA ROLL NO:13920821
MEASLES
INTRODUCTION
 Measles which is also called rubeola ia the most common and
infectious of all the viral infections of childhood.
 It is a frequent cause of ill healthand morbidity, especially in the
undernourished infantsand children below the age of 3 years.
 One attack of this disease leads to life long immunity.
EPIDEMIOLOGY
 CAUSATIVE AGENT: Measles virus or morbilli virus which is a
RNA virus of paramyxoviridae family.
 MODE OF TRANSMISSION: By droplet spread from secretions of
nose and throat because it include catarrhal symptoms.Man is
the only reservior of this infection.
 PERIOD OF INFECTIVITY: 4 days prior to and 5 days after the
appearance of rash.
 INCIDENCE: This disease is common in pre school children.It may
occur in any season but its incidence is higher in winter and
spring.
PATHOLOGY
 The organism infest by invasion of respiratory epithelium.
 Here it undergo local multiplication which leads to viremia.
 Then it spreads to reticuloendothelial system.
 Then there is necrosis of cells which leads to secondary
viremia.
 Then there appears systemic symptoms.
Multinucleated giant cells can be demonstratedboth in
epidermis and oral epithelium by 7 to 11 days.
CLINICAL FEATURES
 INCUBATION PERIOD: 8 to 12 days.
 PRODROMAL PHASE/CATARRHAL PHASE:
 Onset is acute with moderate increase in temperature.
 Dry hacking cough.
 Running nose .
 Sneezing.
 Redness of eyes.
 Excessive lacrimation.
 KOPLIK’S SPOTS:
 These spots appear as greyish or bluish whiye grains of
sand surrounded by reddish areola on inner side of cheek
opposite second molars.
 They appear on 3rd
and 2nd
day of illness.
 They may be single or multiple.
 They increase in number for two to three days and
disappear by the end of 2nd
day of rash.
 ERUPTIVE PHASE:
This phase is approximately starting from 4th
day when
fever rise again.
RASH: Rashes appear in thus stage which are erythematous and
blenches on pressure. They first appear behind the ears, forehead,
face, neck and spresd to trunk, extremities-palms and soles within 3
days and become brownish and doesn’t fade on pressure.
PROGNOSIS
 Rash dissappeared to 4th
day in the order in which they appears.
 Fever and rash generally disappear within a week in
uncomplicated cases.
 It leaves browny desquamation after disappearance of rash.
COMPLICATIONS
 OTITIS MEDIA: It is the complication of respiratory tract, which
causes prolonged morbidity.
 BRONCHIECTASIS: Protracted in infection of lungs with delayed
resolution may be the cause of bronchiectasis.
 ENCEPHALITIS:Due to invasion of brain cells with measles virus
or may be autoimmune response.
 DIGESTIVE SYSTEM: Persistant diarrhoea is common or
appendicitis due to lymphoid tissue blocking the lumen of
appendix.
 MALNUTRITION: Malnutrition occurs severely as a complication
of this disease.
 There may be activation of tuberculosis.
 OTHERS: Depression of cell mediated immunity and energy.
DIAGNOSIS
 It is totally based on clinical features.
 Serological tests for confirmation.
 CBC
 Fluorescent antibody staining for measles antigen.
PREVENTION AND TREATMENT
 There is no specific tretment for this disease.
 Only symptomatic and supportive treatment is done.
Give bath to child daily.
Mouth is washed and teeth is brushed daily.
Give adequate amount of fluid to the child.
For fever paracetamol can be given.
Cough should not to be suppressed as it helps in clearing
mucus from lungs.
If child is vomiting then i/v fluids are given.
Vit A is given orally.
PROPHYLAXIS
 Administration of measles vaccine along with mumps and
rubella (MMR vaccine).
o 1st
dose at 9 to 12 months of age
o 2nd
dose at 15 to 18 months of age
o At a dose of 0.5 ml
o Site of injection is subcutaneously at right upper arm.
ROMANTIKA
 Measles can be correlated with ROMANTIKA in ayurveda.
 Acharya charak has described it in shotha chikitsadhyaya.
 Acharya Madhavakar has called it a type of “Masurika” and
described it.
 Vitiated Kapha and Pitta dosha doshas are the cause of this
disease.
NIDANA
According to Sushrut Nidanasthana chapter 5 , it is an Upsargajanya
vyadhi so its causes are similar to that which are:
 Contact with infected person’s body parts.
 Expiration or nih: shwasa which is its main cause.
 Eating , sitting and sleeping with infected person.
 Sharing clothes and articles with infected persons.
LAKSHANA
According to charaka chikitsa sthana chapter 9 the symptoms are:
 small red rashes all over the body (pidaka)
 fever (jwara)
 burning sensation (daha)
 excessive thirst (trishna)
 itching (kandu)
 anorexia (aruchi)
 common cold (pratishyay)
 redness of eyes (netra roga)
 tiredness (klama)
 depression (avsada)
 diarrhoea (atisara)
 photophobia (prakasha asahiyata)
 excessive weakness (daurbalya)
Jwara is the first symptom and all other symptoms appear after that.
At 3rd
to 4th
day the” PIDAKA” appear at forehear and near the
ears.and then it spreads all over the body. After spread fever recited
and the thin skin over the acne falls off.slowly all syptoms reside
within 15 to 20 days.
TREATMENT
 Tribhuvana kirti rasa: 30 to 60 mg with ardrakha rasa and honey.
 Pravala pishti: 30 to 60 mg with honey.
 Lakshami Narayana rasa+ Gorochana+ pravala pishti taken in
equal parts: 30 to 60 mg with honey or Patoladi kwatha.
MUMPS
It is an acute viral infection also called infectious parotitis or
epidemic parotitis. It is characterised bypainful swelling of salivary
glands especially the parotids and frequently by CNS involvement. The
majority of sufferers i.e. 80 % belong to pediatric age group. A single
attack leads to life long immunity.
EPIDEMIOLOGY
 CAUSATIVE ORGANISM: Mumps virus which is a single stranded
RNA virus belongs to paramyxoviridae family.
 RISK FACTORS: Mumps is endemic world over. May occur in any
age in either sex but most cases occur between 5 and 15 years
of age.infants are rarely involved due to transplacentally
acquired maternal mumps antibodies.
 INCIDENCE: Mumps can occur in any season but its incidence is
highr in winter and spring.
 TRANSMISSION: Direct contact by dropet infection. Direct
contact is through fomites contaminated by infected saliva.
Saliva ishighly infective in this case.
 PERIOD OF INFECTIVITY: 7 days prior to and 9 days after the
appearance of parotid and salivary gland swelling.
PATHOGENESIS
 Virus enters through nose or mouth.
 It proliferates in the parotid gland and respiratory mucosa.
 This is followed by viremia.
 Virus is localised in salivary glands and CNS and may be
recovered from saliva, blood, urine and CSF during acute stage of
illness.
CLINICAL FEATURES
 INCUBATION PERIOD: 2 to 4 weks with an average of 18 days.
 1/3rd
patients remain asymptomatic .
 Symptoms start with fever, headache, nausea, malaise, loss of
apetite.
 SALIVARY MANIFESTATIONS:
 Pain near the lobe of ear and difficulty in chewing within
24 hrs of onset .
 Parotid swelling and area behind angle of jaw appears full.
 Enlarged parotid obliterate mandibular angle
 Opening of stenson duct appear red
 Submaxillary and sublingual glands may also be enlarged.
 EXTRASALIVARY MANIFESTATION:
 Aseptic meningitis.
 Severe headache, vomiting, neck stiffness.
PROGNOSIS
 Prognosis is excellent .
 The disease begin unilaterally but involve other side also within
48-72 hrs in 75% cases.
 Fever and tenderness settle in 1-6 days.
 Swelling disappears in 6-10 days.
COMPLICATIONS
 Orchitis and epididymitis.
 Pancreatitis: uncommon and recover spontaneously within 5-7
days. It may lead to diabetes mellitus.
 In pregnancy: it may increase fatal mortality. Incidence of low
birth weight babies increases.
DIAGNOSIS
 It is based on clinical features.
 Blood count may show leucopenia.
 Compliment fixation test.
 In CSF there is increased pressure, increased proteins and cells.
TREATMENT
 symptomatic treatment is done
 paracetamol and aspirin is given for pain
 warm saline mouth washes
 Rest is usually advised to the child throughout the infection.
 Fluid diet is advised when there is difficulty in chewing.
 child should be isolated until parotid swelling has resolved
prophylaxis: administration of mmr vaccine
 1st
dose at the age of 9-12 months
 2nd
dose at the age of 15-18 months
subcutaneously at right upper arm.
RUBELLA
Rubella which is also called german measles is relatively less
contagious viral disease characterised by mild prodromal symptoms, a
typical eruption and enlargement of cervical lymph nodes. It is
primarily disease of older children and adults. Second attack of this
disease is rare. It isusually a mild illness. Most people who have had
rubella or the vaccine are protected againt the virus for the rest of
their lives. Because of routine vaccination against rubella since 1970,
rubella is now rarely reported.
EPIDEMIOLOGY
 CAUSATIVE ORGANISM: rubella virus which is a ss-RNA virus of
togaviridae family
 MODE OF TRANSMISSION: direct contact by droplet method
 PERIOD OF INFECTIVITY: 5 days prior to and 4 days after the
appearance of rash.
 INCIDENCE: rubella occurs worldwide with seasonal distribution.
Peak incidence of infection is in late winter or early spring. There
have been no major epidemics in the united states since vaccine
licencure in 1969 and the incidence increase by 99%. Continuous
cases of congenital rubella due to infection in unvaccinated,
susceptible young women.
CLINICAL FEATURES
 INCUBATION PERIOD: 14-21 days with an avg. 16 days
 PRODROMAL PHASE:
 it last for a few days
 slight malaise
 tender posterior cervical lymphadenopathy without catarrh.
This phase may be entirely absent or remain unnoticed.
 RASH :1st
visible sign.It is macule which spread from face to
trunk & extremities.Macules later blend.Eruption disappear by
3rd
day.
CONGENITAL RUBELLA SYNDROME
 Infants born to mother who had suffered from
rubella,paticularly in 1st
trimester of pregnancy may suffer from
multiple congenital defects and these are collectively known as
congenital rubella syndrome.
 This disease has three main symptoms:
 cataract
 Cardiac anomalies
 deafness
 other symptoms are:
 growth retardation
 mental retardation
 otitis media
 pancreatitis
 hepatospleenomegaly & hepatitis etc.
DIAGNOSIS
 viral isolation
 serological tests : neutralisation
compliment fixation
hemagglutination inhibition
fluorescent antibody studies
PREVENTION AND TREATMENT
 There is no specific treatment
 Treat complications if any
 Take proper rest
 Increase fluid intake
 PROPHYLAXIS: only reliable means of prevention is
administration of vaccine MMR.
 1st
dose at the age of 9-12 months
 2nd
dose at the age of 15-18 months
 0.5 ml subcutaneously at right upper arm
Measles

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Pertussis/Whooping cough
Pertussis/Whooping coughPertussis/Whooping cough
Pertussis/Whooping cough
 
Measles
MeaslesMeasles
Measles
 
Measles
MeaslesMeasles
Measles
 
Pertussis
PertussisPertussis
Pertussis
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
Lower respiratory tract infection (LRTI) in
Lower respiratory tract infection (LRTI) inLower respiratory tract infection (LRTI) in
Lower respiratory tract infection (LRTI) in
 
Rubella - German Measeles
Rubella - German Measeles Rubella - German Measeles
Rubella - German Measeles
 
Scrub typhus
Scrub typhusScrub typhus
Scrub typhus
 
Chicken pox
Chicken poxChicken pox
Chicken pox
 
Rubella
RubellaRubella
Rubella
 
Chicken pox
Chicken  poxChicken  pox
Chicken pox
 
Chickenpox (varicella) dr harivansh chopra
Chickenpox (varicella) dr harivansh chopraChickenpox (varicella) dr harivansh chopra
Chickenpox (varicella) dr harivansh chopra
 
Pertusis or Whooping cough class presentation
Pertusis or  Whooping cough class presentation Pertusis or  Whooping cough class presentation
Pertusis or Whooping cough class presentation
 
Mumps
MumpsMumps
Mumps
 
Pulmonary TB (Tuberculosis) PPT SlideShare
Pulmonary TB  (Tuberculosis) PPT SlideSharePulmonary TB  (Tuberculosis) PPT SlideShare
Pulmonary TB (Tuberculosis) PPT SlideShare
 
Chicken pox
Chicken poxChicken pox
Chicken pox
 
upper respiratory tract infection
upper respiratory tract infectionupper respiratory tract infection
upper respiratory tract infection
 
Measles
MeaslesMeasles
Measles
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
Pulmonary tuberculosis (tb)
Pulmonary tuberculosis (tb)Pulmonary tuberculosis (tb)
Pulmonary tuberculosis (tb)
 

Ähnlich wie Measles

Ähnlich wie Measles (20)

epidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdfepidofmeasles-180920162327.pdf
epidofmeasles-180920162327.pdf
 
Epidemiology of measles
Epidemiology of measlesEpidemiology of measles
Epidemiology of measles
 
rubella.pptx
rubella.pptxrubella.pptx
rubella.pptx
 
MMR
MMRMMR
MMR
 
Vaccine preventable diseases
Vaccine preventable diseasesVaccine preventable diseases
Vaccine preventable diseases
 
influeza and diptheria -Dr Krishna Smirthi CV.pptx
influeza and diptheria -Dr Krishna Smirthi CV.pptxinflueza and diptheria -Dr Krishna Smirthi CV.pptx
influeza and diptheria -Dr Krishna Smirthi CV.pptx
 
Respiratory and Intestinal infections
Respiratory and Intestinal infectionsRespiratory and Intestinal infections
Respiratory and Intestinal infections
 
Communicable diseases
Communicable diseasesCommunicable diseases
Communicable diseases
 
MEASLES - soon to be eradicated ..!!
MEASLES - soon to be eradicated ..!!MEASLES - soon to be eradicated ..!!
MEASLES - soon to be eradicated ..!!
 
Viral Diseases
Viral DiseasesViral Diseases
Viral Diseases
 
MEASLES - THEORY.ppt
MEASLES - THEORY.pptMEASLES - THEORY.ppt
MEASLES - THEORY.ppt
 
Measles by rehana majeed (1)
Measles by rehana majeed (1)Measles by rehana majeed (1)
Measles by rehana majeed (1)
 
Measles and Rubella
Measles and Rubella Measles and Rubella
Measles and Rubella
 
Pertusis and Varicella
Pertusis and VaricellaPertusis and Varicella
Pertusis and Varicella
 
EPIDEMIOLOGY – COMMUNICABLE DISEASE.pptx
EPIDEMIOLOGY – COMMUNICABLE DISEASE.pptxEPIDEMIOLOGY – COMMUNICABLE DISEASE.pptx
EPIDEMIOLOGY – COMMUNICABLE DISEASE.pptx
 
Measles:AiA007
Measles:AiA007Measles:AiA007
Measles:AiA007
 
Rubell ppt
Rubell pptRubell ppt
Rubell ppt
 
mumps ppt.ppt
mumps ppt.pptmumps ppt.ppt
mumps ppt.ppt
 
Chickenpox and smallpox
Chickenpox  and  smallpoxChickenpox  and  smallpox
Chickenpox and smallpox
 
Fever and rash by Dr.Uma
Fever and rash by Dr.UmaFever and rash by Dr.Uma
Fever and rash by Dr.Uma
 

Mehr von DR.ARVINDER KAUR

ras shastra and bhaishjya kalpana notes
ras shastra and bhaishjya kalpana notesras shastra and bhaishjya kalpana notes
ras shastra and bhaishjya kalpana notesDR.ARVINDER KAUR
 
Polycystic ovarian syndrome
Polycystic ovarian syndromePolycystic ovarian syndrome
Polycystic ovarian syndromeDR.ARVINDER KAUR
 
Govt ayurvedic college patiala history sheets
Govt ayurvedic college patiala history sheetsGovt ayurvedic college patiala history sheets
Govt ayurvedic college patiala history sheetsDR.ARVINDER KAUR
 
History performa for short cse in roga nidan evum vikriti vigyan
History performa for short cse in roga nidan evum vikriti vigyanHistory performa for short cse in roga nidan evum vikriti vigyan
History performa for short cse in roga nidan evum vikriti vigyanDR.ARVINDER KAUR
 
Roga nidan history sheet for long and short case
Roga nidan history sheet for long and short caseRoga nidan history sheet for long and short case
Roga nidan history sheet for long and short caseDR.ARVINDER KAUR
 
1st year syllabus for bams students
1st year syllabus for bams students1st year syllabus for bams students
1st year syllabus for bams studentsDR.ARVINDER KAUR
 
Final year syllabus for bams students
Final year syllabus for bams studentsFinal year syllabus for bams students
Final year syllabus for bams studentsDR.ARVINDER KAUR
 
3rd year syllabus for bams students
3rd year syllabus for bams students3rd year syllabus for bams students
3rd year syllabus for bams studentsDR.ARVINDER KAUR
 
2nd year syllabus for bams students
2nd year syllabus for bams students2nd year syllabus for bams students
2nd year syllabus for bams studentsDR.ARVINDER KAUR
 
bank of questions for 4th year bams
bank of questions for 4th year bamsbank of questions for 4th year bams
bank of questions for 4th year bamsDR.ARVINDER KAUR
 
bank of questions for bams 2nd year
bank of questions for bams  2nd yearbank of questions for bams  2nd year
bank of questions for bams 2nd yearDR.ARVINDER KAUR
 
Practice questions for bams 1st year
Practice questions for bams 1st yearPractice questions for bams 1st year
Practice questions for bams 1st yearDR.ARVINDER KAUR
 
New syllabus for bams 3rd year according to ccim 2k20
New syllabus  for bams 3rd year according to ccim 2k20New syllabus  for bams 3rd year according to ccim 2k20
New syllabus for bams 3rd year according to ccim 2k20DR.ARVINDER KAUR
 
Pakshaghata hemiplegia ayurvedic and modern aspect
Pakshaghata hemiplegia ayurvedic and modern aspectPakshaghata hemiplegia ayurvedic and modern aspect
Pakshaghata hemiplegia ayurvedic and modern aspectDR.ARVINDER KAUR
 
Polyhydramnios and oligohydramnios
Polyhydramnios and oligohydramniosPolyhydramnios and oligohydramnios
Polyhydramnios and oligohydramniosDR.ARVINDER KAUR
 
panchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspect
panchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspectpanchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspect
panchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspectDR.ARVINDER KAUR
 
Measles mumps rubella ayurvedic and modern aspect
Measles mumps rubella ayurvedic and modern aspectMeasles mumps rubella ayurvedic and modern aspect
Measles mumps rubella ayurvedic and modern aspectDR.ARVINDER KAUR
 

Mehr von DR.ARVINDER KAUR (20)

ras shastra and bhaishjya kalpana notes
ras shastra and bhaishjya kalpana notesras shastra and bhaishjya kalpana notes
ras shastra and bhaishjya kalpana notes
 
Polycystic ovarian syndrome
Polycystic ovarian syndromePolycystic ovarian syndrome
Polycystic ovarian syndrome
 
Govt ayurvedic college patiala history sheets
Govt ayurvedic college patiala history sheetsGovt ayurvedic college patiala history sheets
Govt ayurvedic college patiala history sheets
 
History performa for short cse in roga nidan evum vikriti vigyan
History performa for short cse in roga nidan evum vikriti vigyanHistory performa for short cse in roga nidan evum vikriti vigyan
History performa for short cse in roga nidan evum vikriti vigyan
 
Roga nidan history sheet for long and short case
Roga nidan history sheet for long and short caseRoga nidan history sheet for long and short case
Roga nidan history sheet for long and short case
 
1st year syllabus for bams students
1st year syllabus for bams students1st year syllabus for bams students
1st year syllabus for bams students
 
Final year syllabus for bams students
Final year syllabus for bams studentsFinal year syllabus for bams students
Final year syllabus for bams students
 
3rd year syllabus for bams students
3rd year syllabus for bams students3rd year syllabus for bams students
3rd year syllabus for bams students
 
2nd year syllabus for bams students
2nd year syllabus for bams students2nd year syllabus for bams students
2nd year syllabus for bams students
 
bank of questions for 4th year bams
bank of questions for 4th year bamsbank of questions for 4th year bams
bank of questions for 4th year bams
 
bank of questions for bams 2nd year
bank of questions for bams  2nd yearbank of questions for bams  2nd year
bank of questions for bams 2nd year
 
Question bank 3rd year
Question bank 3rd yearQuestion bank 3rd year
Question bank 3rd year
 
Practice questions for bams 1st year
Practice questions for bams 1st yearPractice questions for bams 1st year
Practice questions for bams 1st year
 
New syllabus for bams 3rd year according to ccim 2k20
New syllabus  for bams 3rd year according to ccim 2k20New syllabus  for bams 3rd year according to ccim 2k20
New syllabus for bams 3rd year according to ccim 2k20
 
Alcoholism
AlcoholismAlcoholism
Alcoholism
 
Parada
ParadaParada
Parada
 
Pakshaghata hemiplegia ayurvedic and modern aspect
Pakshaghata hemiplegia ayurvedic and modern aspectPakshaghata hemiplegia ayurvedic and modern aspect
Pakshaghata hemiplegia ayurvedic and modern aspect
 
Polyhydramnios and oligohydramnios
Polyhydramnios and oligohydramniosPolyhydramnios and oligohydramnios
Polyhydramnios and oligohydramnios
 
panchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspect
panchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspectpanchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspect
panchvidha kshaya kalpana phanta kalpana ayurvedic and modern aspect
 
Measles mumps rubella ayurvedic and modern aspect
Measles mumps rubella ayurvedic and modern aspectMeasles mumps rubella ayurvedic and modern aspect
Measles mumps rubella ayurvedic and modern aspect
 

Kürzlich hochgeladen

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 

Kürzlich hochgeladen (20)

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 

Measles

  • 1.
  • 2. GOVERNMENT AURVEDIC COLLEGE AND HOSPITAL, PATIALA. SESSION 2018-19 DEPARTMENT OF PEDIATRICS COMPILTION ON: INFECTIOUS DISEASES (MEASLES, MUMPS AND RUBELLA) B.A.M.S.3RD YEAR SUBMITTED TO : SUBMITTED BY: DR. K.K.CHOPRA MANDEEP KAUR DR.SHALINI B.A.M.S.3RD YEAR DR.ASHWANI RANA ROLL NO:13920821
  • 3.
  • 4.
  • 5. MEASLES INTRODUCTION  Measles which is also called rubeola ia the most common and infectious of all the viral infections of childhood.  It is a frequent cause of ill healthand morbidity, especially in the undernourished infantsand children below the age of 3 years.  One attack of this disease leads to life long immunity. EPIDEMIOLOGY  CAUSATIVE AGENT: Measles virus or morbilli virus which is a RNA virus of paramyxoviridae family.  MODE OF TRANSMISSION: By droplet spread from secretions of nose and throat because it include catarrhal symptoms.Man is the only reservior of this infection.  PERIOD OF INFECTIVITY: 4 days prior to and 5 days after the appearance of rash.  INCIDENCE: This disease is common in pre school children.It may occur in any season but its incidence is higher in winter and spring. PATHOLOGY  The organism infest by invasion of respiratory epithelium.  Here it undergo local multiplication which leads to viremia.  Then it spreads to reticuloendothelial system.
  • 6.  Then there is necrosis of cells which leads to secondary viremia.  Then there appears systemic symptoms. Multinucleated giant cells can be demonstratedboth in epidermis and oral epithelium by 7 to 11 days. CLINICAL FEATURES  INCUBATION PERIOD: 8 to 12 days.  PRODROMAL PHASE/CATARRHAL PHASE:  Onset is acute with moderate increase in temperature.  Dry hacking cough.  Running nose .  Sneezing.  Redness of eyes.  Excessive lacrimation.  KOPLIK’S SPOTS:
  • 7.  These spots appear as greyish or bluish whiye grains of sand surrounded by reddish areola on inner side of cheek opposite second molars.  They appear on 3rd and 2nd day of illness.  They may be single or multiple.  They increase in number for two to three days and disappear by the end of 2nd day of rash.  ERUPTIVE PHASE: This phase is approximately starting from 4th day when fever rise again. RASH: Rashes appear in thus stage which are erythematous and blenches on pressure. They first appear behind the ears, forehead, face, neck and spresd to trunk, extremities-palms and soles within 3 days and become brownish and doesn’t fade on pressure. PROGNOSIS  Rash dissappeared to 4th day in the order in which they appears.  Fever and rash generally disappear within a week in uncomplicated cases.  It leaves browny desquamation after disappearance of rash. COMPLICATIONS  OTITIS MEDIA: It is the complication of respiratory tract, which causes prolonged morbidity.  BRONCHIECTASIS: Protracted in infection of lungs with delayed resolution may be the cause of bronchiectasis.
  • 8.  ENCEPHALITIS:Due to invasion of brain cells with measles virus or may be autoimmune response.  DIGESTIVE SYSTEM: Persistant diarrhoea is common or appendicitis due to lymphoid tissue blocking the lumen of appendix.  MALNUTRITION: Malnutrition occurs severely as a complication of this disease.  There may be activation of tuberculosis.  OTHERS: Depression of cell mediated immunity and energy. DIAGNOSIS  It is totally based on clinical features.  Serological tests for confirmation.  CBC  Fluorescent antibody staining for measles antigen. PREVENTION AND TREATMENT  There is no specific tretment for this disease.  Only symptomatic and supportive treatment is done. Give bath to child daily. Mouth is washed and teeth is brushed daily. Give adequate amount of fluid to the child. For fever paracetamol can be given. Cough should not to be suppressed as it helps in clearing mucus from lungs.
  • 9. If child is vomiting then i/v fluids are given. Vit A is given orally. PROPHYLAXIS  Administration of measles vaccine along with mumps and rubella (MMR vaccine). o 1st dose at 9 to 12 months of age o 2nd dose at 15 to 18 months of age o At a dose of 0.5 ml o Site of injection is subcutaneously at right upper arm. ROMANTIKA  Measles can be correlated with ROMANTIKA in ayurveda.  Acharya charak has described it in shotha chikitsadhyaya.  Acharya Madhavakar has called it a type of “Masurika” and described it.  Vitiated Kapha and Pitta dosha doshas are the cause of this disease. NIDANA According to Sushrut Nidanasthana chapter 5 , it is an Upsargajanya vyadhi so its causes are similar to that which are:  Contact with infected person’s body parts.  Expiration or nih: shwasa which is its main cause.  Eating , sitting and sleeping with infected person.  Sharing clothes and articles with infected persons.
  • 10. LAKSHANA According to charaka chikitsa sthana chapter 9 the symptoms are:  small red rashes all over the body (pidaka)  fever (jwara)  burning sensation (daha)  excessive thirst (trishna)  itching (kandu)  anorexia (aruchi)  common cold (pratishyay)  redness of eyes (netra roga)  tiredness (klama)  depression (avsada)  diarrhoea (atisara)  photophobia (prakasha asahiyata)  excessive weakness (daurbalya) Jwara is the first symptom and all other symptoms appear after that. At 3rd to 4th day the” PIDAKA” appear at forehear and near the ears.and then it spreads all over the body. After spread fever recited and the thin skin over the acne falls off.slowly all syptoms reside within 15 to 20 days. TREATMENT  Tribhuvana kirti rasa: 30 to 60 mg with ardrakha rasa and honey.  Pravala pishti: 30 to 60 mg with honey.  Lakshami Narayana rasa+ Gorochana+ pravala pishti taken in equal parts: 30 to 60 mg with honey or Patoladi kwatha.
  • 11. MUMPS It is an acute viral infection also called infectious parotitis or epidemic parotitis. It is characterised bypainful swelling of salivary glands especially the parotids and frequently by CNS involvement. The majority of sufferers i.e. 80 % belong to pediatric age group. A single attack leads to life long immunity. EPIDEMIOLOGY  CAUSATIVE ORGANISM: Mumps virus which is a single stranded RNA virus belongs to paramyxoviridae family.  RISK FACTORS: Mumps is endemic world over. May occur in any age in either sex but most cases occur between 5 and 15 years of age.infants are rarely involved due to transplacentally acquired maternal mumps antibodies.  INCIDENCE: Mumps can occur in any season but its incidence is highr in winter and spring.  TRANSMISSION: Direct contact by dropet infection. Direct contact is through fomites contaminated by infected saliva. Saliva ishighly infective in this case.  PERIOD OF INFECTIVITY: 7 days prior to and 9 days after the appearance of parotid and salivary gland swelling. PATHOGENESIS  Virus enters through nose or mouth.  It proliferates in the parotid gland and respiratory mucosa.  This is followed by viremia.
  • 12.  Virus is localised in salivary glands and CNS and may be recovered from saliva, blood, urine and CSF during acute stage of illness. CLINICAL FEATURES  INCUBATION PERIOD: 2 to 4 weks with an average of 18 days.  1/3rd patients remain asymptomatic .  Symptoms start with fever, headache, nausea, malaise, loss of apetite.  SALIVARY MANIFESTATIONS:  Pain near the lobe of ear and difficulty in chewing within 24 hrs of onset .  Parotid swelling and area behind angle of jaw appears full.  Enlarged parotid obliterate mandibular angle  Opening of stenson duct appear red  Submaxillary and sublingual glands may also be enlarged.  EXTRASALIVARY MANIFESTATION:  Aseptic meningitis.  Severe headache, vomiting, neck stiffness.
  • 13. PROGNOSIS  Prognosis is excellent .  The disease begin unilaterally but involve other side also within 48-72 hrs in 75% cases.  Fever and tenderness settle in 1-6 days.  Swelling disappears in 6-10 days. COMPLICATIONS  Orchitis and epididymitis.  Pancreatitis: uncommon and recover spontaneously within 5-7 days. It may lead to diabetes mellitus.  In pregnancy: it may increase fatal mortality. Incidence of low birth weight babies increases. DIAGNOSIS  It is based on clinical features.  Blood count may show leucopenia.  Compliment fixation test.  In CSF there is increased pressure, increased proteins and cells. TREATMENT  symptomatic treatment is done  paracetamol and aspirin is given for pain  warm saline mouth washes
  • 14.  Rest is usually advised to the child throughout the infection.  Fluid diet is advised when there is difficulty in chewing.  child should be isolated until parotid swelling has resolved prophylaxis: administration of mmr vaccine  1st dose at the age of 9-12 months  2nd dose at the age of 15-18 months subcutaneously at right upper arm. RUBELLA Rubella which is also called german measles is relatively less contagious viral disease characterised by mild prodromal symptoms, a typical eruption and enlargement of cervical lymph nodes. It is primarily disease of older children and adults. Second attack of this disease is rare. It isusually a mild illness. Most people who have had rubella or the vaccine are protected againt the virus for the rest of their lives. Because of routine vaccination against rubella since 1970, rubella is now rarely reported. EPIDEMIOLOGY  CAUSATIVE ORGANISM: rubella virus which is a ss-RNA virus of togaviridae family  MODE OF TRANSMISSION: direct contact by droplet method  PERIOD OF INFECTIVITY: 5 days prior to and 4 days after the appearance of rash.
  • 15.  INCIDENCE: rubella occurs worldwide with seasonal distribution. Peak incidence of infection is in late winter or early spring. There have been no major epidemics in the united states since vaccine licencure in 1969 and the incidence increase by 99%. Continuous cases of congenital rubella due to infection in unvaccinated, susceptible young women. CLINICAL FEATURES  INCUBATION PERIOD: 14-21 days with an avg. 16 days  PRODROMAL PHASE:  it last for a few days  slight malaise
  • 16.  tender posterior cervical lymphadenopathy without catarrh. This phase may be entirely absent or remain unnoticed.  RASH :1st visible sign.It is macule which spread from face to trunk & extremities.Macules later blend.Eruption disappear by 3rd day. CONGENITAL RUBELLA SYNDROME  Infants born to mother who had suffered from rubella,paticularly in 1st trimester of pregnancy may suffer from multiple congenital defects and these are collectively known as congenital rubella syndrome.  This disease has three main symptoms:  cataract  Cardiac anomalies  deafness
  • 17.  other symptoms are:  growth retardation  mental retardation  otitis media  pancreatitis  hepatospleenomegaly & hepatitis etc. DIAGNOSIS  viral isolation  serological tests : neutralisation compliment fixation hemagglutination inhibition fluorescent antibody studies PREVENTION AND TREATMENT  There is no specific treatment  Treat complications if any  Take proper rest  Increase fluid intake  PROPHYLAXIS: only reliable means of prevention is administration of vaccine MMR.  1st dose at the age of 9-12 months  2nd dose at the age of 15-18 months  0.5 ml subcutaneously at right upper arm